Citations (0)
Keep up to date with the latest research on this topic with citation updates for this article.
Future Oncology
Volume 19, 2023 - Issue 16
Drug Evaluation
Margetuximab in HER2-positive metastatic breast cancer
William J Gradishar1 Division of Hematology/Oncology, Northwestern University, Chicago, IL60611, USACorrespondence[email protected]
https://orcid.org/0000-0002-2772-3140
https://orcid.org/0000-0002-2772-3140, Ruth O’Regan2 Department of Medicine, University of Rochester Medical Center, Rochester, NY14642, USAhttps://orcid.org/0000-0001-6984-3741
https://orcid.org/0000-0001-6984-3741, Mothaffar F Rimawi3 Department of Medicine, Baylor College of Medicine, Houston, TX77030, USAhttps://orcid.org/0000-0002-4284-5656
https://orcid.org/0000-0002-4284-5656, , & Hope S Rugo5 Department of Medicine (Hematology/Oncology), University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA94158, USAhttps://orcid.org/0000-0001-6710-4814
https://orcid.org/0000-0001-6710-4814